Recent Updates
Recently added Catalysts
IDYA

IDEAYA Biosciences and Boston Childrens Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome a Rare Disease Associated with Genetic Mutation of GNAQ

Key Takeaway: IDEAYA Biosciences and Boston Childrens Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome a Rare Disease Associated with Genetic Mutation of GNAQ

Full Press Release Details

IDEAYA Biosciences and Boston Childrens Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome a Rare Disease Associated with Genetic Mutation of GNAQ.
Last updated: Jan 10, 2020